Human Macrophage Differentiation via TREM2 Without M-CSF
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for inducing differentiation of macrophages from hematopoietic progenitor cells require the addition of cytokines like M-CSF, GM-CSF, or IL-34, resulting in macrophages without proliferative capacity and limited culture expansion.
Innovation Solution
Culturing human hematopoietic progenitor cells in a medium without M-CSF or GM-CSF, using a TREM2 signal activator such as lipids or antibodies to induce macrophages, allowing proliferation and culture expansion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If M-CSF or GM-CSF is added to the medium for differentiating macrophages from hematopoietic progenitor cells, then macrophage differentiation is achieved, but the resulting macrophages lack proliferative capacity and cannot be expanded in culture
Solution Approach 1:
The patent changes the chemical parameters of the culture medium by replacing traditional cytokines (M-CSF, GM-CSF) with a defined medium containing lipid components and basic growth factors. This parameter change enables macrophages to maintain proliferative capacity while achieving differentiation, resolving the contradiction between reliable differentiation and productive expansion
Solution Approach 2:
The patent extracts and removes the essential cytokine requirement (M-CSF/GM-CSF) from the differentiation process by using a cytokine-defined medium approach. By taking out the cytokine dependency, the patent enables macrophages to differentiate and proliferate without the suppressive effects of traditional cytokine treatment
2Manufacturing precision
If multiple cytokines and growth factors are used to induce differentiation from iPSCs to macrophages, then differentiation efficiency is improved, but the process complexity and culture requirements increase
Solution Approach 1:
The patent extracts and eliminates the requirement for complex extracellular matrix coatings and multiple cytokine supplements by developing a cytokine-defined medium system. This simplifies the culture system while maintaining high differentiation efficiency, directly addressing the contradiction between manufacturing precision and device complexity
Solution Approach 2:
The patent changes the medium composition parameters to a defined system with specific lipid components and basic growth factors, replacing the undefined serum and matrix-dependent system. This parameter change reduces culture system complexity while preserving or improving differentiation efficiency
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
A method of producing human macrophages includes culturing human hematopoietic progenitor cells in a medium that substantially does not contain either a macrophage colony-stimulating factor or a granulocyte-macrophage colony-stimulating factor, in presence of a TREM2 signal activator.